Palmisano Brian T, Rottman Jeffrey N, Wells Quinn S, DiSalvo Thomas G, Hong Charles C
Division of Cardiovascular Medicine, Center for Inherited Heart Disease, Vanderbilt Heart and Vascular Institute, Vanderbilt University School of Medicine, Nashville, TN 37232, USA.
Cardiology. 2011;119(1):47-53. doi: 10.1159/000329834. Epub 2011 Aug 4.
Most sudden cardiac deaths in young athletes are caused by previously undetected inherited cardiac diseases. Here, we report a case of a young male athlete in whom a presumptive diagnosis of hypertrophic cardiomyopathy (HCM) was made following a near sudden cardiac death. Although his imaging studies initially suggested HCM, a detailed clinical and genetic evaluation of the patient and his asymptomatic father led to the diagnosis of arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVD) in both. DNA sequencing revealed that each individual was heterozygous for two rare variants in the PKP2 and DSC2 genes, both of which were previously shown to be associated with ARVD and to encode desmosomal proteins, i.e. the previously reported splicing variant c2489 + 1A > G in the PKP2 gene and the novel p.I109M variant in the DSC2 gene. Imaging and electrophysiologic studies further supported a diagnosis of ARVD in the father. This case highlights the importance of detailed clinical evaluation and genetic testing of family members when dealing with sudden cardiac death or unexplained cardiomyopathies in the young.
年轻运动员中大多数心脏性猝死是由先前未被发现的遗传性心脏疾病引起的。在此,我们报告一例年轻男性运动员病例,该运动员在心脏接近骤停后被初步诊断为肥厚型心肌病(HCM)。尽管其影像学检查最初提示为HCM,但对该患者及其无症状父亲进行详细的临床和基因评估后,两人均被诊断为致心律失常性右心室心肌病/发育不良(ARVD)。DNA测序显示,每个人在PKP2和DSC2基因中均为两个罕见变异的杂合子,这两个基因先前均被证明与ARVD相关且编码桥粒蛋白,即PKP2基因中先前报道的剪接变异c2489 + 1A > G和DSC2基因中的新型p.I109M变异。影像学和电生理研究进一步支持了父亲患有ARVD的诊断。该病例强调了在处理年轻人心脏性猝死或不明原因心肌病时,对家庭成员进行详细临床评估和基因检测的重要性。